<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139097">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01290237</url>
  </required_header>
  <id_info>
    <org_study_id>10-11-0561</org_study_id>
    <nct_id>NCT01290237</nct_id>
  </id_info>
  <brief_title>Use of a Loading Dose of Vancomycin in Pediatric Dosing</brief_title>
  <official_title>The Use of a Loading Dose of Intravenous Vancomycin Will Achieve Therapeutic Concentration Earlier Than Conventional Pediatric Dosing: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vancomycin is an antibiotic administered to children or adults for many types of infections.
      While it has been used to treat infections of children for more than 50 years we are still
      not completely certain about the best dose to use when starting treatment with this
      medication.

      This study is intended to evaluate whether giving a new higher dose of vancomycin for the
      first dose will help us get to the desired amount in the body more quickly then the usual
      first dose. Half of the patients would get the new higher dose and the other half of
      patients will get the typical first dose. Only the first dose is changed and all doses that
      follow are the same in both groups and are doses typically used for children.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI leaving institution, slow enrollment
  </why_stopped>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of patients whose vancomycin trough reached 15 mcg/mL, 8 hours after the first vancomycin dose, in loading dose group as compared to control group</measure>
    <time_frame>8 hours after the first dose of vancomycin</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pharmacokinetic parameters for vancomycin in the study population</measure>
    <time_frame>within 48 hours after receiving the first dose of vancomycin</time_frame>
    <description>mean volume of distribution (to be measured in L) and mean elimination rate constant (to be measured in hour^-1) for vancomycin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Vancomycin loading dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous vancomycin 30 mg/kg/dose once, followed 8 hours later by 20 mg/kg/dose every 8 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous vancomycin 20 mg/kg/dose every 8 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous vancomycin hydrochloride</intervention_name>
    <description>see description of study arms</description>
    <arm_group_label>Vancomycin loading dose</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Receiving care at Children's Hospital Boston

          -  Prescribed intravenous vancomycin by their physician

        Exclusion Criteria:

          -  Weight above 67 kg

          -  Pre-existing renal dysfunction (creatinine clearance &lt; 50 ml/min/1.73m2)

          -  Known hearing impairment

          -  Recent intravenous vancomycin treatment (within 7 days)

          -  Undergoing procedure with anticipated moderate-severe blood loss
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alicia A Demirjian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434. Review. Erratum in: Am J Health Syst Pharm. 2009 May 15;66(10):887.</citation>
    <PMID>19106348</PMID>
  </reference>
  <reference>
    <citation>Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009 May;28(5):398-402. doi: 10.1097/INF.0b013e3181906e40.</citation>
    <PMID>19295465</PMID>
  </reference>
  <reference>
    <citation>Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF; Infectious Diseases Society of America.. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4. Erratum in: Clin Infect Dis. 2011 Aug 1;53(3):319.</citation>
    <PMID>21208910</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <lastchanged_date>March 8, 2012</lastchanged_date>
  <firstreceived_date>January 28, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Boston</investigator_affiliation>
    <investigator_full_name>Alicia Demirjian</investigator_full_name>
    <investigator_title>Clinical Fellow, Pediatric Infectious Diseases</investigator_title>
  </responsible_party>
  <keyword>vancomycin</keyword>
  <keyword>loading dose</keyword>
  <keyword>pharmacokinetic</keyword>
  <keyword>pediatric</keyword>
  <keyword>Methicillin-Resistant Staphylococcus aureus (MRSA)</keyword>
  <keyword>Serious infection with Gram positive bacteria</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
